Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France
NCT01211652 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8186
Last updated 2013-01-29
Summary
The purpose of this study is to assess in general population NSAID and gastroprotective agent utilization and compliance in elderly people.
Conditions
- Healthy
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Dr Jean-Francois Bretagne · Service gastro-enterologie et hepatologie CHRU Pontchaillou 35033 RENNES cedex France
-
Pr Gerard Thiefin · Service Hepato-Gastroenterologie CHU Reims 51092 REIMS cedex France
-
Mrs Genevieve BONNELYE · KantarHealth - France138, avenue Marx Dormoy 92120 Montrouge cedex
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2010-11-30
- Completion
- 2010-11-30
Countries
- France
Study Locations
More Related Trials
-
The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users
NCT01814943 ·Status: COMPLETED
-
Physiopathology of Rapid Aspirin Desensitization
NCT01118546 ·Status: COMPLETED
-
NSAIDs in Coronary Artery Disease Patients
NCT01402804 ·Status: COMPLETED
-
First Approach for Aspirin Misuse Objective Screening
NCT02997436 ·Status: COMPLETED ·Phase: NA
-
Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
NCT01952392 ·Status: COMPLETED
-
the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy
NCT03230851 ·Status: UNKNOWN ·Phase: PHASE4
-
ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase
NCT04912505 ·Status: COMPLETED ·Phase: PHASE2
-
Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
NCT05718531 ·Status: UNKNOWN ·Phase: PHASE3
-
Aspirin Resistance in Coronary Artery Disease
NCT00753935 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy
NCT01888575 ·Status: COMPLETED
-
An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel
NCT01210339 ·Status: COMPLETED ·Phase: PHASE1
-
AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).
NCT03317002 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.
NCT00425074 ·Status: COMPLETED ·Phase: PHASE1
-
Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.
NCT00734123 ·Status: UNKNOWN ·Phase: PHASE4
-
Duration of Platelet Inhibition by Aspirin
NCT00671021 ·Status: COMPLETED
-
Prospective Real-world Registry Describing Treatment Regimens
NCT03942913 ·Status: UNKNOWN
-
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
NCT01104441 ·Status: COMPLETED
-
Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Acute Coronary Syndrome
NCT00548587 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic Trial, of Slow Release ASA, in Platelet Functionalism, a Long Term Treatment Period
NCT00501254 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Antiplatelet Drug Resistances and Ischemic Events
NCT00501423 ·Status: COMPLETED
-
Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;
NCT04586972 ·Status: COMPLETED
-
Gastrointestinal Bleeding is Blood Loss in the Digestive Tract, Classified as Upper or Lower. Ischemic Heart Disease is Due to Blocked Heart Arteries. Antiplatelet Drugs Help Prevent Heart Attacks But Increase GI Bleeding Risk, Especially When Used Together as Dual Therapy.
NCT07125651 ·Status: NOT_YET_RECRUITING
-
Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes
NCT01322711 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects
NCT03698513 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
NCT01586975 ·Status: COMPLETED ·Phase: PHASE2/PHASE3